![Biological E's Corbevax gets DCGI nod as a Heterologous Covid Booster Dose Biological E's Corbevax gets DCGI nod as a Heterologous Covid Booster Dose](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjNk0FmPugr15YjXiaSfv2qhrSg-zLA12mS8Vo0MQJGinCmp1F6B3aannGUsYuIxrClc4zBvUdKANEEPmkhWuFhJoFIXlLtTCjOVxl-N7NbSmTF4w0W9jTEqyEklxUm2b28G_8NyEIbBklPknlMYY3ZDYItvbmEcJT21Lo4wY9cVQdtl0d4c1lyuUg4HA/w320-h240-rw/Covid%20Booster%20Dose.jpg)
- Recently the Drug Controller General of India (DCGI) approved Biological E’s Corbevax and it becomes the first vaccine to get to be used as a heterologous booster for adults who have either received two shots of Covaxin or Covishield.
- As of now, India was using a homologous booster shot for all precaution doses. Now, this become the first heterologous booster for adults.
- Corbevax shot can be booked through the Co-WIN portal by anyone who wished to take a shot.
- Corbevax booster dose provided significant enhancement in immune response and excellent safety profile required for an effective booster.
- Apart from that, it has been claimed that there were no severe or adverse events of interest for 3 months of follow-up after the booster dose was administered.
- Homologous boosters increased neutralizing antibody titers by a factor of 4 to 20, whereas heterologous boosters increased titers by a factor of 6 to 73.
Question:
Q.1 DGCA approved Corbevax Booster is a __________type of booster which is used for adults?a. Homologous
b. Heterologous
c. Mixed
d. Double strain booster
c. Mixed
d. Double strain booster